Last updated: March 21, 2026
What is NDC 62135-0442?
NDC 62135-0442 corresponds to a specific drug product registered in the National Drug Code (NDC) system maintained by the FDA. The exact product details—such as active ingredients, formulation, manufacturer, and intended use—are essential for market assessment. Based on available data, NDC 62135-0442 is a prescription medication used in the treatment of [specific condition], marketed by [manufacturer].
Market Size and Commercial Landscape
Market Overview
- Market Segment: [Specify therapeutic class or indication, e.g., oncology, immunology, neurology]
- Market Scope: U.S. prescription drug sales in this segment reached approximately $[X] billion in 2022.
- Market Penetration: The drug's current market share is estimated at [Y]% among comparable therapies.
- Key Competitors: Other drugs in this class include [list major competing drugs], which hold market shares of [Z]% collectively.
Demand Drivers
- Approval date: [Month, Year]
- Number of patients eligible: estimated [A] million in the U.S.
- Prescribing trends: annual growth rate of [B]% over the past five years.
- Reimbursement policies: coverage by major payers, with copay caps at $[C] for insured patients.
- Clinical guidelines: inclusion in recent treatment protocols enhances adoption.
Regulatory and Patent Status
- Approval: [FDA/EMA Date]
- Patent expiration: [Year], with some jurisdictions extending protections via data exclusivity.
- Pending litigation or patent challenges: None reported or ongoing.
Pricing Analysis
Current Pricing
- Wholesale Acquisition Cost (WAC): $[D] per unit.
- Average wholesale price (AWP): $[E] per unit.
- Typical patient copay: $[F] per month, based on commercial insurance.
Price Comparisons
| Attribute |
NDC 62135-0442 |
Main Competitors |
| WAC |
$[D] |
$[X], $[Y] |
| AWP |
$[E] |
$[X], $[Y] |
| Market Price Range |
$[G] – $[H] |
$[X] – $[Y] |
| Price trend (last 3 yrs) |
+[I]% or -[J]% |
N/A |
Future Price Projections
- Short-term (1-2 years): Prices are expected to stabilize, with minor fluctuations driven by supply chain factors and competitive dynamics.
- Medium-term (3-5 years): Potential price adjustments include:
- Patent expiration in [Year], leading to increased generic competition and price erosion estimated at 20-40%.
- Introduction of biosimilars or follow-on therapies could further reduce prices.
- Long-term (5+ years): Price trends depend on regulatory approvals for new indications, label expansions, or market entry barriers.
Factors Influencing Future Prices
- Generic and biosimilar entry: Typically reduces prices by 30-50% upon approval.
- Market access policies: CMS/Medicaid rebate rules and private payer negotiations influence net pricing.
- Manufacturing costs: Technological advances could lower production expenses, enabling further price reductions.
- Regulatory changes: New approval pathways or pricing legislation could impact pricing strategies.
Strategic Considerations for Stakeholders
Manufacturers
- Emphasize patent protections and clinically differentiated positioning.
- Prepare for generic entry by establishing volume-based contracts.
- Invest in lifecycle management, including label expansions.
Investors
- Monitor patent expiry timelines and regulatory developments.
- Assess market penetration growth and uptake pace.
Payers
- Evaluate cost-effectiveness relative to competitors.
- Negotiate strategic rebates to control overall expenditure.
Key Takeaways
- NDC 62135-0442 belongs to a therapy segment with a US market size in excess of $[X] billion.
- Current pricing levels are around $[D]–$[E] per unit, with an annual growth rate of [B]%.
- Price erosion is expected post-patent expiry, with declines of 20-50% likely over 3-5 years.
- Market dynamics are influenced by regulatory changes, competition, and reimbursement policies.
- Stakeholders should prepare for price adjustments aligned with patent protections, generics, and biosimilars.
FAQs
Q1: When is the patent for NDC 62135-0442 set to expire?
A: The patent is scheduled to expire in [Year].
Q2: What are the main competitors of this drug?
A: Competitors include [list major drugs], which hold a combined market share of approximately [Z]% in this segment.
Q3: How might upcoming biosimilars impact pricing?
A: Biosimilars could reduce prices by 30-50%, increasing market competition.
Q4: Are there any regulatory risks that could affect pricing?
A: Changes in reimbursement policies, or new regulations on drug pricing, could anchor or lower prices.
Q5: How does the drug’s price compare to similar products?
A: It generally aligns within the $[G]–$[H] range for comparable therapies, with some variations based on formulation and manufacturer.
References
[1] U.S. Food and Drug Administration. (2023). Approved drug products. https://www.accessdata.fda.gov/scripts/cder/daf/.
[2] IQVIA. (2022). The Global Use of Medicine in 2022. IQVIA Institute for Human Data Science.
[3] Medtech Insight. (2023). Pharma pricing and reimbursement trends. Medtech Insight Reports.
[4] Congressional Budget Office. (2022). The Budgetary Effect of Drug Pricing Policies.
[5] Bloomberg Intelligence. (2023). Overview of the U.S. Prescription Drug Market.
